The effect of medication-related support on the quality of life of patients with vasculitis in relapse and remission

Journal of Rheumatology

Volumn 38, Issue 4, 2011, Pages 709-715

  Carpenter, Delesha M ^a   Kadis, Jessica A ^a,b   Devellis, Robert F ^a,b   Hogan, Susan L ^a   Jordan, Joanne M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Quality of life; Social support; Vasculitis

Indexed keywords

ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; DISEASE COURSE; DOCTOR PATIENT RELATION; FAMILY ATTITUDE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; RELAPSE; REMISSION; SOCIAL SUPPORT; VASCULITIS;

ADULT; AGED; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PHYSICIANS; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE; REMISSION INDUCTION; SELF-HELP GROUPS; VASCULITIS;

EID: 79953295354     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100808     Document Type: Article

References (32)

1. Walsh M, Jayne D. Rituximab in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis and systemic lupus erythematosus: past, present and future. Kidney Int 2007;72:676-82. (Pubitemid 47373785)
2. Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 2005;143:621-31.
3. Mukhtyar C, Luqmani R. Disease-specific quality indicators, guidelines, and outcome measures in vasculitis. Clin Exp Rheumatol 2007;25 Suppl 47:120-9.
4. Herlyn K, Reinhold-Keller E, Zeidler A, Raspe H, Gutfleisch J, Peter HH, et al. Health-related quality of life in primary systemic vasculitides [abstract]. Arthritis Rheum 1998;41 Suppl:S538.
5. Hoffman GS, Drucker Y, Cotch MF, Locker GA, Easley K, Kwoh K. Wegener's granulomatosis: Patient-reported effects of disease on health, function, and income. Arthritis Rheum 1998;41:2257-62. (Pubitemid 29009385)
6. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gutfleisch J, Peter HH, Gross WL. Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis. Arthritis Rheum 2002;47:320-5. (Pubitemid 34627701)
7. Boomsma MM, Bijl M, Stegeman CA, Kallenberg CG, Hoffman GS, Tervaert JW. Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosis. Arthritis Rheum 2002;47:196-201. (Pubitemid 34303847)
8. Koutantji M, Harrold E, Lane SE, Pearce S, Watts RA, Scott DG. Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 2003;49:826-37. (Pubitemid 37523636)
9. Jayne D, Rasmussen N, Andrassy K, Bacon PA, Tervaert JWC, Dadoniene J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. New Engl J Med 2003;349:36-44. (Pubitemid 36765101)
10. Seo P, Min Y, Holbrook JT, Hoffman GS, Merkel PA, Spiera R, et al. Damage caused by Wegener's granulomatosis and its treatment: Prospective data from the Wegener's Granulomatosis Etanercept Trial. Arthritis Rheum 2005;52:2168-78. (Pubitemid 40994340)
11. Thorpe C. Illness self-management among adults living with ANCA small vessel vasculitis [dissertation]. Chapel Hill: University of North Carolina at Chapel Hill; 2006, 247 p.
12. Akar S, Can G, Binicier O, Aksu K, Akinci B, Solmaz D, et al. Quality of life in patients with Takayasu's arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients. Clin Rheumatol 2008;27:859-65. (Pubitemid 351818759)
13. Carpenter DM, Thorpe CT, Lewis MA, DeVellis RF, Hogan SL. Health-related quality of life for patients with vasculitis and their spouses. Arthritis Care Res 2009;61:259-65.
14. Cotch MF. The socioeconomic impact of vasculitis. Curr Opinion Rheumatol 2000;12:20-3. (Pubitemid 30036683)
15. Revenson TA, Schiaffino KM, Majerovitz SD, Gibofsky A. Social support as a double-edged sword: The relation of positive and problematic support to depression among rheumatoid arthritis patients. Soc Sci Med 1991;33:807-13.
16. Manne SL, Zautra AJ. Spouse criticism and support: their association with coping and psychological adjustment among women with rheumatoid arthritis. J Personality Soc Psychol 1989;56:608-17.
17. Uchino B. Social support and health: A review of physiological processes potentially underlying links to disease outcomes. J Behav Med 2006;29:377-87. (Pubitemid 44134207)
18. Cutrona CE. Social support in couples. Thousand Oaks, CA: Sage Publications; 1996.
19. Okun MA, Keith VM. Effects of positive and negative social exchanges with various sources on depressive symptoms in younger and older adults. J Gerontol B Psychol Sci Soc Sci 1998;53:4-20.
20. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 2004;23:207-18. (Pubitemid 38365280)
21. Helgeson VS, Cohen S. Social support and adjustment to cancer: Reconciling descriptive, correlational, and intervention research. Health Psychol 1996;15:135-48. (Pubitemid 126468487)
22. Yates B. The relationships among social support and short- and long-term recovery outcomes in men with coronary heart disease. Res Nurs Health 1995;18:193-203.
23. Neuling S, Winefield H. Social support and recovery after surgery for breast cancer: frequency and correlates of supportive behaviours by family, friends, and surgeon. Soc Sci Med 1988;27:385-92.
24. Dunkel-Schetter C. Social support in cancer: findings based on patient interviews and their implications. J Social Issues 1984;40:77-98.
25. Carpenter DM, DeVellis RF, Hogan SL, Fisher EB, DeVellis BM, Jordan JM. The effect of conflicting medication information and physician support on medication adherence for chronically ill patients. Patient Educ Couns 2010;81:169-76.
26. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item health survey 1.0. Health Econ 1993;2:217-27.
27. Ware JE, Kosinski M. SF-36 physical and mental health summary scales: A manual for users of Version 1. Lincoln, RI: QualityMetric Inc.; 2005.
28. Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Hetland M. Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important? J Rheumatol 2010;37:285-90.
29. McElhone K, Abbott J, Teh L-S. A review of health related quality of life in systemic lupus erythematosus. Lupus 2006;15:633-43. (Pubitemid 44682824)
30. Bae SC, Hashimoto H, Karlson EW, Liang MH, Daltroy LH. Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus. J Rheumatol 2001;28:1245-51. (Pubitemid 32510494)
31. Revenson TA, Abraido-Lanza A, Majerovitz SD, Jordan C. Couples coping with chronic illness: what's gender got to do with it? In: Revenson TA, Kayser K, Bodenmann G, editors. Couples coping with stress. Washington, DC: American Psychological Association; 2005:137-56.
32. Sable-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005;143:632-8. (Pubitemid 41552527)